Yun Mao
About Yun Mao
Yun Mao is the Vice President of Portfolio Strategy & Integration at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical industry.
Vice President, Portfolio Strategy & Integration
Yun Mao currently holds the position of Vice President, Portfolio Strategy & Integration at Bristol Myers Squibb. Based in New Jersey, United States, he has been with the company since November 2019. His role involves overseeing the strategic aspects of the company's portfolio, ensuring optimal integration and alignment with corporate goals, leveraging over 20 years of experience in the pharmaceutical industry.
Previous Roles
Before joining Bristol Myers Squibb, Yun Mao worked at Celgene as an Alliance Compound Leader from 2018 to 2019. Prior to his tenure at Celgene, he spent 17 years at Merck & Co., Inc in Rahway, New Jersey, serving as the Executive Director. His extensive experience at Merck sharpened his skills in leadership, project management, and strategic development within the pharmaceutical sector.
Educational Background
Yun Mao's educational journey began at Peking University, where he earned a Bachelor's of Science in Chemistry from 1991 to 1996. He then pursued advanced studies at the University of Minnesota, obtaining a Ph.D. in Analytical Chemistry between 1996 and 2001. His academic background has provided a strong foundation for his roles in the pharmaceutical industry.
Experience in Pharmaceutical Industry
With over two decades of experience, Yun Mao has built a robust career within the pharmaceutical industry. His professional trajectory includes significant roles at both Merck & Co., Inc and Celgene, and currently at Bristol Myers Squibb. His expertise spans analytical chemistry, portfolio strategy, and integration, making him a seasoned executive in the field.